Neoplasm by Histologic Type
1 clinical trials · Condition
◉ Watch Neoplasm by Histologic Type
| Record | Firm | Date |
|---|---|---|
| Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects (NCT02798406) | DNAtrix, Inc. | 2016-10-06 |
Track Neoplasm by Histologic Type automatically
Every clearance here is in the API, with alerts when new ones post.